{
  "id": 3799385,
  "title": "Federal court rejects PhRMA challenge to Medicare drug price negotiation",
  "url": "https://urgent.news/2026/08/27/federal-court-rejects-phrma-challenge-to-medicare-drug-price",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-27T18:52:33.000Z",
  "source": {
    "name": "The Hill",
    "slug": "the-hill",
    "url": "https://thehill.com/policy/healthcare/6055400-fifth-circuit-rejects-phrma-lawsuit/"
  },
  "original_language": "en",
  "account": null,
  "summary": "A federal appeals court on Wednesday ruled against a lawsuit filed by representatives of the pharmaceutical industry challenging the federal Medicare drug price negotiation program, finding that drugmakers are not entitled to sell their products to Medicare at a price they would prefer. The U.S. Court of Appeals for the Fifth Circuit affirmed a prior...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "NPR",
        "title": "Drugstores say Medicare's $50 obesity drug program is catching on",
        "url": "https://urgent.news/2026/08/26/drugstores-say-medicares-50-obesity-drug-program-is-catching-on",
        "published": "2026-08-26T21:11:42.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}